ADVANCES IN THE DIAGNOSIS PATHOGENESIS AND TREATMENT OF CIDP PDF

Download Citation on ResearchGate | Advances in the diagnosis, pathogenesis and treatment of CIDP | Chronic inflammatory demyelinating. This Review highlights the recent advances in diagnosing CIDP, provides an update on the immunopathology including new target antigens. CIDP is an acquired immune-mediated inflammatory disorder sometimes Advances in the diagnosis, pathogenesis and treatment of CIDP.

Author: Arashir Akira
Country: Reunion
Language: English (Spanish)
Genre: Automotive
Published (Last): 27 July 2006
Pages: 488
PDF File Size: 1.68 Mb
ePub File Size: 2.60 Mb
ISBN: 320-6-67750-188-1
Downloads: 63220
Price: Free* [*Free Regsitration Required]
Uploader: Mazulabar

From This Paper Figures, tables, and topics from this paper. This paper treat,ent been referenced on Twitter 1 time over the past 90 days. BoumpasGeorge K.

Advances in the diagnosis, pathogenesis and treatment of CIDP

Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy. References Publications referenced by this paper. Chronic inflammatory demyelinating polyneuropathy CIDP is the most common chronic autoimmune neuropathy.

Topics Discussed in This Paper. Showing of references. Armati Journal of the peripheral nervous system: Antonis FanouriakisDimitrios T. Showing of 60 extracted citations. Current diagnosis of CIDP: MRI assessment including apparent diffusion coefficient.

An update on the management of chronic inflammatory demyelinating polyneuropathy. This Review highlights the recent advances in diagnosing CIDP, provides an update on the immunopathology including new target antigens, and discusses current treatments, ongoing challenges and future therapeutic directions. Despite clinical challenges in diagnosis—owing in part to the existence of disease variants, and different views on how many electrophysiological abnormalities are needed to document demyelination—consensus criteria seem to have been reached for research or clinical practice.

  FORTIGATE 60C DATASHEET PDF

Advances in our understanding of the underlying immunopathology in CIDP have identified new targets for future therapeutic efforts, including T cells, B cells, and transmigration and transduction molecules.

Untitled Document

Subcutaneous IgG for chronic inflammatory demyelinating polyneuropathy Marinos C. New cido and scoring systems represent emerging tools with the potential to predict therapeutic responses and identify patients with active disease for enrollment into clinical trials.

Brannagan Journal of the peripheral nervous system: Maintenance therapy with IVIg can induce sustained remission, increase quality of life and prevent further axonal loss, but caution is needed to avoid overtreatment. John David PollardPatricia J. Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Search for additional papers on this topic.

Pathogenesis and treatment of CNS lupus. Citations Publications citing this paper. Bertsias Current opinion in rheumatology Evidence from Human and Animal Studies: Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: Skip to search form Skip to main content.

Advances in the diagnosis, pathogenesis and treatment of CIDP.

By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy PolicyTerms of Serviceand Dataset License. An open label clinical trial of complement inhibition in multifocal motor neuropathy.

  2N6565 DATASHEET PDF

Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies. Kenneth Craig Gorson Therapeutic advances in neurological disorders Commonly used immunosuppressive drugs offer minimal benefit, necessitating the development of new therapies for treatment-refractory patients.

Despite clinical challenges in diagnosis-owing in part to the existence of disease variants, and different views on how many electrophysiological abnormalities are needed to document demyelination-consensus criteria seem to have been reached pf research or clinical practice. Dalakas The Lancet Neurology